There are 20 cell and gene therapies on Europe's market versus 43 in the U.S. Find out more about this ecosystem.

This new tool, known as minimal, versatile genetic perturbation technology (mvGPT), combines the powers of gene editing, ...

MaxCyte Inc. (NASDAQ: MXCT) is a global developer of next-generation cell therapies. They provide crucial technology for cell ...

Since two groundbreaking treatments were approved in late 2023, only a handful of patients have been able to access the ...

A pivotal experience in a Hopkins lab inspired Roger Hajjar, '86, to forge a career at the intersection of engineering and ...

Jason Foster, CEO of Ori Biotech, discusses the difficulties preventing more widespread adoption of these advanced therapies.

At J.P. Morgan, most biopharma executives expressed a neutral stance on the incoming administration, but just days later, ...

The study found that the number of advanced therapy Phase I trials in the UK nearly doubled since the same time in 2023.

With increasing demand for cell and gene therapies, mesenchymal stem cells (MSCs) have gained attention for their versatility ...

Viralgen and Axovia Therapeutics are partnering to develop and manufacture a gene therapy for the treatment of retinal dystrophy in patients with Bardet-Biedl Syndrome (BBS) caused by biallelic ...

The therapy is a critical treatment option for various life-threatening disease. Earlier, GST on gene therapy was set at 12 ...